4-Hydroxy-2-oxopyrrolidine-N-acetamide, 97%

Name: 4-Hydroxy-2-oxopyrrolidine-N-acetamide, 97% | 62613-82-5
Brand: J&K Chemical
SKU: JK930729_5_G
Price: 15.7 USD
Availability: OutOfStock

Cat. No JK930729_5_G

Vendor: J&K Chemical

Product Information

Product Name

4-Hydroxy-2-oxopyrrolidine-N-acetamide, 97%

Brand Name

J&K

Product Number

930729

CAS

62613-82-5

Molecular Formula

C6H10N2O3

Molecular Weight

158.16

Certificate of Analysis (COA)

COA not found

General Information

Synonyms

2-(4-Hydroxy-2-oxo-1-pyrrolidinyl)acetamide
Oxiracetam

PubChem CID

4626

IUPAC Name

2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetamide

InChI Key

IHLAQQPQKRMGSS-UHFFFAOYSA-N

SMILES

C1C(CN(C1=O)CC(=O)N)O

Properties

Melting Point

172

Safety Information

Storage Condition

Store at 2-8℃

References Data Source From Pubchem

Oxiracetam Improves Cognitive Disorder in AD by Modulating AMPAR Subunits GluA1/GluA2 Kinetics

Publication Name: Cell Biochemistry and Biophysics

Publication Date: 2026-02-25

DOI: 10.1007/s12013-026-02025-z

Vascular cognitive impairment and dementia: Prevention, treatments, mechanisms and management options for the future

Publication Name: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Publication Date: 2026-01-19

DOI: 10.1038/s41386-026-02331-3

Docking Based Screening of Potent Natural Components to Combat COVID-19-Associated Brain Fog

Publication Name: Global Trends in Health, Technology and Management II

Publication Date: 2026

DOI: 10.1007/978-3-032-12320-6_22

Efficacy and safety of L-oxiracetam on cognitive function in patients with traumatic brain injury: a multicentre, randomised, double-blind, phase 3 clinical trial

Publication Name: Signal Transduction and Targeted Therapy

Publication Date: 2025-12-12

DOI: 10.1038/s41392-025-02492-5

Targeting NMDA receptors in pain management: therapeutic innovations through piracetam repurposing

Publication Name: Naunyn-Schmiedeberg's Archives of Pharmacology

Publication Date: 2025-12-08

DOI: 10.1007/s00210-025-04859-5

4-Hydroxy-2-oxopyrrolidine-N-acetamide, 97%

Product Information

General Information

Properties

Safety Information

References Data Source From Pubchem

Oxiracetam Improves Cognitive Disorder in AD by Modulating AMPAR Subunits GluA1/GluA2 Kinetics

Vascular cognitive impairment and dementia: Prevention, treatments, mechanisms and management options for the future

Docking Based Screening of Potent Natural Components to Combat COVID-19-Associated Brain Fog

Efficacy and safety of L-oxiracetam on cognitive function in patients with traumatic brain injury: a multicentre, randomised, double-blind, phase 3 clinical trial

Targeting NMDA receptors in pain management: therapeutic innovations through piracetam repurposing